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 Since time immemorial, replacement of man’s organs have 
always found fascination amongst us. And among all 
replacements  bone transplantations are the most widely 
performed. 
“Bone is the most commonly transplanted tissue in the body 
than any other tissue or organ except blood”.  
 Transplanted bone, tendon and ligaments are used 
extensively in orthopedics, neurosurgery, dental surgery and 
plastic surgery for procedures including repair of fractures and 
damage caused by illness and injury. . The application and the 
scope of allografts are the most in orthopaedics.  
 
ALLOGRAFTS IN VARIOUS SURGICAL RECONSTRUCTIONS 
 
 
 
 
 
oral& MF surgery  
 0.75 % 
Gen.surgery 2% 
plastic surgery 
dental 1%
ENT 0.8%
Ophthal 15% 
neurosurgery 4.5 % 
orthopaedic
s 
69 % 
5.35%
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Bone is a unique tissue in that its ability to regenerate is 
more predictable than any other tissue in the body. Bone is often 
destroyed by infection, tumor, trauma and implanted materials 
and has to be replaced to restore structure and function. 
Bridging bone defects remains a challenging problem in 
orthopedic practice. The options available are 
1. Vascularised autografts 
2. Non Vascularised autografts 
3. Custom made prosthesis 
4. Biomaterials e.g. ceramics, 
5. Allografts 
Likewise ceramics are available from only in certain 
countries and very expensive. With the development of bone 
banks all over the world, bone allografts have become more 
readily available with high standards of safety for transplantation 
in patients. 
Bone grafting is one of the most frequent operations 
performed. Autografts remain the gold standard as they are 
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osteoconductive as well as osteoinductive and have osteogenic 
cells. 
Most of the time, amount of graft required is small and 
harvesting bone from the iliac crest and fibula is enough. When 
the graft requirement is larger in the massive defects or in 
children, where the autograft availability is small and harvesting 
can damage the open growth plates, the role of allografts comes 
into play. Autografting has many disadvantages like donor life 
morbidity, increased blood loss and increased operating time. 
Complications involving the iliac bone-graft donor site are not 
uncommon. Although some of these complications may not be serious, 
they add to the patient's discomfort and prolong the convalescence. 
Complications secondary to graft removal from the ilium include 
1. Major blood loss 
2. Hematoma 
3. Nerve injury (neuroma formation) 
4. Severe pain (chronic pain) 
5. Hernia 
6. Cosmetic deformity 
7. Fracture 
8. Necessity for sacroiliac joint surgery 
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9. Pelvic instability 
10. Hip subluxation 
11. Gait disturbance 
12. Peritoneal injury 
13. Ureteral injury 
14. Heterotopic bone formation 
15. Infection 
Allograft have been proved to be useful in massive defects, 
spinal fusions, large joint defects and reconstructive of bone 
tumors in spite of several short timings. Allografts have further 
extended the reconstruction abilities of surgeon and provide 
innovative option for biologic reconstruction with less patient 
morbidity.   
The advantages of allografts are 
1. Allografts can be stored for long time up to 6 years in case 
of freeze dried allografts and freeze dried demineralized 
allografts and 5 years for deep frozen allografts 
2. It is cheaper than metallic implants 
3. Easy to obtain and enormous availability of the graft 
4. Decreased donor site morbidity 
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5. Biologic form of fixation (i.e., after incorporation 
allografted area becomes the quality of host bone) 
6. Immunologic response is very minimal after storage hence 
there is no role of immunosuppressive drugs 
7. Allografts of all dimensions can be prepared and used for 
deficient conditions 
8. Soft tissues and ligament attachment are possible with 
allografts . 
9. Can be stored for a long time 
10. Shortened operating time 
11. Good biologic bed for tendon and ligament 
reconstruction 
12. Biological Reconstruction avoids long term 
complications of prostheses and ceramics (loosening etc) 
13. Enormous savings in costs 
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APPLICATIONS  
OF  
ALLOGRAFTS 
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APPLICATIONS OF ALLOGRAFTS IN ORTHOPAEDICS 
z Musculoskeletal Oncology   
Reconstruction after Resection 
z Large structural allografts 
z Nonstructural allografts (morselized cancellous or 
cortico cancellous bone chips) 
z Traumatic Bone Defect 
z Structural or non structural allograft 
z Spinal surgery  & Revision joint arthroplasty 
z Bone stock augmentation 
z Morcellized cancellous allografts 
z Sports Medicine 
z Ligament reconstruction 
z Meniscal allograft 
z Osteochondral allograft  
 14
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2500 years back Sushrutha used skin and bone allografts 
for nasal reconstruction. 
 In 1881 William McEwen of Glasgow performed the first 
successful bone allograft and initiated the modern practice of 
bone grafting. He successfully transferred segments of bone 
from a rachitic patient to the humerus of a three year old child 
suffering from osteomyelitis, and he performed rib graft to 
replace mandible. 
 Lexer in 1908 performed 29 allogenic whole joint 
transplantation. In 1914 phemister advocated bone grafting to 
enhance the process of creeping substitution. In 1935 – 1937 
Bush and Wilson successfully stored allograft at 10 to 20o C 
in New York. 
 Langer of Canada showed that reaction to allografts was 
greatly reduced by freezing the graft. 
 In 1956, Albee, the first orthopaedic surgeon started US 
bone bank in New York. 
 In 1960, Ethelene oxide sterilization has been used for 
bones. 
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 In 1974, Radiation sterilization focused to be alterative for 
ETO sterilization on the grounds of safety and cost.  
In 1978 Burchand et al described three patterns of allograft 
incorporation.  
In 1983 W.W. Tomford suggested the use of glycerol and 
demethyl sulphoxide to maintain the viability of cartilage 
during freezing.  
In 1989 M.R.Urist described the use of  bone morphogenic 
protein. 
 In 1990 international atomic agency published guidelines 
for the radiation sterilization. In 1990 there was 30 tissue 
banks in USA and 31 tissue banks in Europe. 
 The first allograft transplantation in a Government Hospital  
in India was performed by Prof. Mayil Vahanan Natarajan in 
2003 at the Govt. General Hospital, Chennai . 
 In 2005, the first bone bank in a Government Hospital in 
India was started in Government General Hospital, Chennai. 
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A successful bone graft has to incorporate into the skeletal 
system of the host; graft incorporation depends on its size, 
structure, position, fixation and genetic composition. The role of 
the grafts in stimulating incorporation encompasses 
osteoconduction, osteoinduction and osteogenesis. 
Osteoconduction and creeping substitution are the main 
mechanisms in the incorporation of allografts, Allografts act as a 
scaffold for in growth and it is referred as osteoconduction. 
Graft Incorporation occurs in following Stages 
1. Revascularisation 
2. Graft resorption 
3. Creeping substitution, new osteons laid over the Allograft. 
4. Graft remodeling. 
Revascularisation occurs by invasion of the capillary 
sprouts from the host bed and resorption of the old matrix 
follows with the investing osteoclasts & osteoblasts around the 
blood vessels that invade the graft. 
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After the laid of Osteons, callus formation ensures around 
the allografts serially which remodels in the course of time to 
ensure adequate incorporation. 
Large Allografts may be incorporated in processing serial 
stress fractures that results in graft remodeling, periodically a 
region of stress concentration may microfracture followed by 
local remodeling. Later it proceeds to the whole length of the 
massive allografts. It takes a long time for the massive allografts 
to get incorporated into the skeletal system of the host. 
 
Major type of allografts and their incorporation  
 
1. Allogenic Demineralised Bone matrix (DBM) 
2. Morcellised (cancellous) allogenic bone 
3. Massive Structural allograft 
1. Cortical 
2. Cortico-cancellous  
3. Osteochondral 
4. Ligaments and Tendons 
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MAJOR TYPE OF ALLOGRAFTS 
Demineralized Bone Matrix 
It is formed after a mild acid extraction of cadaveric bone 
that removes the mineral phase, leaving the collagen, growth 
factors and non collagenous proteins that offer the intrinsic 
properties of osteoconduction and osteoinduction. It is powder 
that is mixed with a carrier. It is also available as gels, putties, 
pastes and fabric. It gets quickly revascularized and provides no 
structural support and moderately osteoinductive also. Within 1 
hour, Implantation is followed by platelet aggregation, hematoma 
formation and inflammation characterized by migration of 
leucocytes. 
Fibroblast like mesenchymal cells undergone cellular 
differentiation into chondrocytes around 5 days. Chondrocytes 
produce cartilage matrix, which is mineralized. After 10-12 days 
vascular invasion with osteoblastic cells, new bone is formed 
opposite to the surface of the mineralized cartilage. Remodeling 
and replacement of these compound structures with new host 
bone ensues. With time, all the implanted DBM is resorbed and 
replaced with host bone. 
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DEMINERALISED BONE 
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MORCELLIZED AND CANCELLOUS ALLOGENIC BONE 
Limited mechanical support and are osteoconductive only. 
Derived from either cancellous or cortical bone ranging from 
chips of sizes 0.5 to 3 mm diameter. They are characterized by 
an open, porous almost lattice like physical structure so that 
there is no physical improvement to the in growth of vessels. 
The same stage of hemorrhage, inflammation, vascular 
ingrowth osteoid formation, remodeling and graft integration as 
in case of allografts take place. They are osteoconductive only 
and more resistant to compression. This may as weight bearing 
structures during the process of graft incorporation. They do not 
suffer the transient loss on mechanical strength that as resorption 
is not necessary for revascularisation.  
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MASSIVE ALLOGRAFTS 
The incorporation of massive allografts is a slow and 
incomplete process. Immune response is produced by the host 
even through the long storage in the deep freezer in order to 
reduce the immunogenicity. New bone formation from the 
periosteum of the host bone at the host graft junction is essential 
for the union at allograft host junction. 
 Creeping substitution and graft remodeling occurs in the 
slower phase and taken long time in achieving fusions. 
Optimizing the host - interface improves the functional outcome 
of massive bone allografts 
 
 
 
. 
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CORTICOCANCELLOUS AND CORTICAL ALLOGRAFTS 
They provide structural support and osteoconductive to a 
limited degree. The process of incorporation is slower than the 
DBM and cancellous allografts as resorption is necessary for 
revascu1arisation. 
 
 
 
 
 
 
 
 
TENDO LIGAMENTOUS ALLOGRAFTS 
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 Organs and tissues transplanted into host incompatible 
animals or humans will induce an immune response. There is 
substantial evidence that bone, like other allogenic tissues, also 
induces such a response as a result of the recognition of a variety 
of potential alloantigens by the host’s immune system. These 
antigens are capable of stimulating the full range of immune 
activities including cellular responses, antibodies and cytokine 
release. 
IMMUNOLOGICAL COMPONENTS 
Bone is a complex tissue comprised of many constituents 
capable of acting as sources of antigen. These include the non-
cellular antigens of the extra cellular matrix such as collagen 
together with non-collagenous proteins (proteoglycans,  
glycoprotiens, etc.) as well as cells that express the major 
histocompatibility antigens. The primary cause of the host 
immune response in bone allograft transplantation are the cells 
of the bone marrow, primarily leukocytes. Reduction or removal 
of such cells by processing, freezing, freeze-drying or irradiation 
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reduces these cellular elements and thus lowers the likelihood of 
an immune response. 
Several studies have demonstrated that after transplantation 
of frozen bone or soft tissue grafts that an immune response is 
generated causing antibody formation in up to 75% of the 
patients. This does seem to affect the outcome of massive bone 
transplantation. For tendon allografts it does not seem to have 
clinical importance. Transplantation of freeze-dried grafts does 
not cause antibody formation. Freezing and freeze-drying 
procedures decrease the antigenicity of bone. Irradiation of 
bone not only sterilizes the bone but also destroys its 
antigenicity. 
HISTOCOMPATIBILITY MATCHING 
Experimental results shows that matching does reduce 
immunogenicity and improves the outcome of bone allografts. 
However, the fact that the tissue transplanted after irradiation is 
only inert bone with minimal tissue antigenicity precludes the 
need for HLA matching as also the need for pre or post 
transplantation immunosuppressive therapy. Potential benefits 
in clinical practice which were initially unresolved have all been 
now proven. 
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The three most commonly used preservation methods are 
1. Deep-freezing - -80degree – 5years 
2. Freeze-drying (Lyophilization) - -20degree –6 months 
3. Cryo preservation – -160 degree 
 
FRESH FROZEN ALLOGRAFT (DEEP FREEZING) 
In this method the graft is collected and frozen slowly in two 
steps; first to -20 degree Celsius for 8 hours, followed by 
freezing to -80 degree Celsius in order to stop all enzymatic 
activity. Allografts can be preserved by deep-freezing up to 5 
years. Advantages of deep freezing are 
1. Long bones such as femur and tibia are stored as fresh frozen 
allografts. 
2. reduces the immunogenicity of the allografts,  
3. Fresh frozen  bone has got superior strength 
Disadvantages are 
1. High cost of operation of the freezers 
2. Requires regular monitoring of the temperature of the 
freezer.  
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FREEZE DRYING (freeze dried allografts) 
Freeze drying on lyophilisation is a process in which 
frozen bone is dehydrated by sublimation. Tissue moisture passes 
directly from the solid phase to the vapor phase and is converted 
to ice on the condenser of the freeze nitrogen. 
A vaccum is maintained in the freeze dryer during the 
process, ensuring that bottles of bone allografts are sterilely 
sealed.This process allows tissue to maintained at room 
temperature for at least years or as long as the vaccum, seals 
remain unbroken. 
Advantages of freeze-drying are 
1. It can be kept at room temperature so storage made easy and 
cheap. 
2. Reduced antigenicity as compared to deep freezing. 
3. Transfer of disease is likely 
Disadvantages are 
1. Decreased torsional and bending strength of cortical grafts. 
2. Not a suitable technique to preserve long bones. 
3. It should be reconstituted by immersion in normal saline 
before use  
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CRYOPRESERVATION 
The lower the temperature the greater the reduction of molecular 
activity, including enzymatic activity. At -160 degree Celsius the 
temperature of the liquid nitrogen, essentially all-molecular 
action is stopped and tissue can be stored indefinitely. 
   By cryopreservation allografts can be stored for life. Most of 
the bone banks in the world don’t prefer the cryopreservatives 
due to 
its high cost and  
4. Electrical deep freezer is as effective as liquid nitrogen 
preservation. 
5. Rapid turn over of tissue makes it unnecessarily to store them 
indefinitely. 
6. Liquid nitrogen may increase the brittleness of bone due to 
immediate crystallization of water that occurs upon rapid 
exposure to very low temperature. 
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The implantation of an allograft into the body carries with 
it an inherent risk of infection. It is extremely important to 
reduce the rate of infection by appropriate sterilization of the 
allografts. Sterilization has been defined as the process or act of 
inactivating  all form of life, especially microorganisms. Aseptic 
procurement of allografts from donors who has little risk of 
infection in sterile operating rooms doesn’t need a secondary 
sterilization. But allografts from the cadaveric bones need 
secondary sterilization wherever the procurement has taken 
place. The sterilization of allografts is an important inevitable 
process needs to be taken strictly in order to get the success of 
bone transplantation. 
The commonly used sterilization methods are 
1. Chemical like ethylene oxide 
2. Radiation sterilisation using gamma rays 25 Kgy 
3. WHO protocol is pasteurization at 60degree Celsius for 30 
min followed by radiation for 25 Kgy for all grafts – 
cadaveric donors HIV protection 
4. Autoclaving 
Autoclaving 
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Bacteria are more readily killed by moist heat than dry 
heat. Steam kills bacteria by denaturing their protein. 121 degree 
Celsius for 15 to 20 minutes is the best method of steam 
sterilization. Autoclaving is not recommended by American 
Association Of Tissue Banks because it alters the structure of 
protein and alters the bone strength. 
Ethylene oxide 
Ethylene oxide is applied in a gaseous state in mixture with 
inert diluents such as carbon dioxide, Freon (dichioro difluro 
methane). After sterilization the residual ethylene oxide is 
replaced by flushing inert gas like carbon dioxide. Ethylene 
oxide sterilization of allografts also has lost its popularity 
because of its carcinogenic property of allografts. 
Radiation sterilization 
 Two types of radiation are employed for sterilization 
namely ionizing radiation and non-ionising. Ultra violet rays are 
a non-ionising radiation most effective at 253.7 micron 
wavelength. It is mainly used for surface sterilization as it has 
very low penetration. Ionizing radiation includes high  energy 
electrons generated from accelerated electro magnetic rays such 
as gamma rays emitted by radioisotope Cobalt60 and Caesium 
 36
137 and X-rays generated by X-ray machine. Ionizing radiation 
kills all types of microorganisms through the ionization process 
and usually has enough energy for useful penetration into solids 
and liquids of tissue. These rays can break and change the DNA 
strands. The treatment does not heat up tissue materials 
significantly and are widely used for industrial sterilization of 
the heat sensitive medical and laboratory products. Therefore 
this has gained popularity in sterilization of allografts. 
Effect of preservation & sterilization: 
Freezing bone decreases its tensile and compression 
strength by about 10 %. Freeze drying decreases torsional 
strength by about 5O% and compressive by 10%. Bending 
strength has been shown to be lowered up to 20% by each of its 
methods. Other physical modes of sterilization like autoclaving 
and pasteurization affects mechanical properties to greater 
extent. So that the graft can be used only where there is no need  
for structural support. 
Radiation sterilization causes little change in the strength 
of structural allograft (3 mega rads of irradiation). 
 
 
 37
 
 
 
COMPLICATIONS  
 
 
 
 
 
 
 
 
 
 38
 The following are the various complications of allografts. 
1. Infection 
2. Nonunion 
3. Graft fracture 
4. Transmission of infectious diseases 
5. Graft resorption 
6. Cartilage fragmentation 
7. Implant failure 
Infections are the most dreadful enemy for allograft 
reconstruction. Proper sterilization techniques, proper surgical 
techniques and good soft tissue cover will decrease the incidence 
of infection. Chemotherapy and radiotherapy will increase the 
incidence of infection by suppressing the immune mechanisms of 
the individual and revascularisation potential of the graft. 
Staphylococcus epidermidis is found to be the most common 
bacterial infection in the allografts. 
Bone allografts have been implicated in transmitting 
tuberculosis, HIV, Hepatitis and bacterial infections to recipient. 
To prevent or at least minimize the risk of transmission of 
infectious disease, several steps are taken by surgeons and bone 
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banks. An important initial approach is to judiciously use bone 
allografts only when needed and to consider the use of auto 
grafts, alternative non human graft material or sterilized bone 
allografts  whenever possible. However, the most important 
approach is exercised by the tissue bank donor coordinator who 
carefully obtains a medical and social history excluding those 
suspect to be at risk of HIV, hepatitis or other viral or bacterial 
infections. 
Graft fracture and failure of graft incorporation are frequently 
found when massive allografts are used. This is not a problem 
with demineralised allografts, cancellous chips when used for 
fusion for spinal surgeries, cavity defects and impaction grafting 
in revision hip arthroplasty.. 
Graft resorption occur in some individuals to immune 
reactions of individual toward the graft. This occurs usually in 
patients frozen articular grafts. This is usually rare complication. 
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DISEASE TRANSMISSION WITH ALLOGRAFTS 
Allografts are prone for disease transmission if the proper 
preventive steps and adherence to strict donor screening steps are 
not followed. 
Bacterial and virus transmission have been reported with 
fresh frozen bone allografts. The disease transmission is rare in 
freeze dried bone allografts and demineralized freeze dried bone 
allografts. 
The following bacterial and viral disease infectious agents 
have been reported in the use of allografts 
1. Group A Streptococci 
2. HIV virus 
3. Hepatitis C virus 
4. Hepatitis B virus 
5. Treponema pallidum 
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Preventive Steps 
Transmission of infection can be prevented by strict 
adherence to certain guideline with respect to procurement 
processing and sterilization of bone grafts 
1. Procurement of the allografts is the most important step in 
preventing the transmission of infection. Following exclusion 
criteria should be considered while collecting the allografts. 
a) High risk group donors 
b) Testing for HIV / HCV / HBsAg / VDRL. 
Always one should retest for HIV/ HCV antibodies after 
the donation to exclude donor during window period 
c) Occult disease in donor on autopsy. 
d) Donor bone tip should be tested for bacterial contamination at 
the time of procurement and final packaging. Tissue should be 
culture negative at that time of official packaging 
e)Adherence to strict guidelines with the respect to processing 
and sterilization of the bone grafts. 
 
 
 
 42
 
 
 
  RECENT ADVANCES 
 
 
 
 
 43
NEWER VISTAS IN BONE REPAIR IN THE 21ST CENTURY  
As our understanding of the biology of bone formation 
keeps widening, surgeon and scientists have started exploring 
hitherto unknown “Grey Zones” in tissue engineering to enhance 
bone healing. The following are the options available to the 21st  
century Orthopaedic surgeon. (by the order of their introduction 
into use)  
Bone Morphogenetic Proteins 
 They have the most osteoinductive potential amongst all 
bone substitutes. Govender ,et al reported faster union, fewer 
infections, and fewer secondary interventions in a study group 
treated with 12 mg of BMP-2 . 
Ceramics -  in the form of calcium phosphate pastes, putties. 
BUT….. 
• The use of milligram dosages when the body BMP levels 
are in the range of nanograms clearly poses concerns of 
dose safety. 
• They are very expensive. Hence their role has to be very 
clearly outlined by more randomized trials to mandate their 
use in patients.  
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CELL BASED THERAPIES 
STEM CELL THERAPY-  
The  use of injectable osteoprogenitor stem cells have been on 
trial recently. They are Mesenchymal Stem Cells(MSC) which 
are pluripotent cells with the capability to generate cells of the 
local environment’s need. 
GENE THERAPY 
Modification of the patient’s genes to “ turn on” the 
osteoprogenitor cells.this is done in two methods. 
• In Vivo Method- introducing an “altered” Adeno virus into 
the patient to stimulate/ modify  the genes. 
• Ex Vivo method- produce genetically “altered” stem cells  
for injection into the patient. 
BUT… 
• Multiple injections are necessary  
• Expensive therapy. 
• The potential unexplored possibility of uncontrolled 
cellular proliferation 
 
 45
    
 
AIM  OF  THE  STUDY 
 
  
 
To evaluate the rates of fusion of allografts and the 
analysis of their outcome in various spine fusion surgeries  
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The materials for this study was based on a prospective 
study conducted at the Department of Orthopaedics and 
Traumatology, Government General Hospital, Chennai from May 
2006 till November 2008 
Inclusion Criteria are  
1. All vertebral fractures & fracture dislocations requiring 
stabilisation. 
2. Spondylolysis, 
3. Spondylolisthesis patients 
4. Caries spine 
5. Kyphoscoliosis correction 
 
Exclusion criteria are  
1. Age >55 yrs,  
2. chronic nicotine users 
3. diabetes mellitus 
4. presence of any other co-morbid conditions affecting the 
microvasculature thereby influencing the rates of fusion. 
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IN THIS STUDY ………….. 
As this study involves ethical issues with the transfer of 
biomaterial between patients, the need for a streamlined 
screening and documentation was felt.  
The Institutional Ethical Committee clearance was obtained.   
The following are the various aspects of allograft procurement 
and processing that was followed in our Bone Bank. 
 PROCUREMENT (Sterile Double Jar Technique) 
Prior to procurement Donor consent was obtained in the 
prescribed format. Screening of the prospective donor for HIV 
I,II, HbSAg, HCV, VDRL, was carried out. 
 Femoral head (undiseased- # NoF) obtained from hip 
replacements are washed are normal saline and packed in pre- 
irradiated poly-ethylene TFC (PET)  jars in sterile packages.  
Screening forms            
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Pre-irradiated sterile PET jar  with Double cover. 
 
Packaged femoral head 
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ALLOGRAFT  PROCESSING  EQUIPMENTS AT OUR BONE BANK 
 
 
LAMINAR AIR FLOW CHAMBER 
 
 
ULTRASONIC BATH 
 
 
ETO STERILISER 
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STORAGE -  THE CRUX OF OUR BONE BANK 
 Both the pre- and post sterilization femoral heads are 
stored at -80* centigrade in Two Deep Freezers in the Bone 
Bank. 
 
 
 
 52
STERILISATION-  GAMMA IRRADIATION 
The allografts were irradiated upto 25KGy at The Kidwai 
Institute of Oncology, Bangalore. Irradiation has very little 
effects on the tensile strength of the allograft. Apart from 
femoral heads procured here, imported sterilized, long bone 
allografts were also preserved in the Deep Freezer. 
DEEP FROZEN IRRADIATED ALLOGRAFT TRIPLE PACKS 
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FRAMING A PROTOCOL: 
Our own Bone Banking Protocol was framed based on 
International screening guidelines. 
DOCUMENTATION: 
At each step of the banking of allografts record maintenance was 
properly done and regularly updated. The records were also 
computerized. 
 
 
 54
BONE BANK PROTOCOL 
Donor consent,screening 
 
Procurement of the bone (femoral heads, 
condyles, bone tendon grafts) 
  
 
Processing & Sterile packaging 
 
Donor screening after 3 months          
  
 
graft discarded 
Irradiation at 25 KGy 
Preservation at -80 * ( Deep Freezer) 
 
Proper patient selection. 
Screening of the patient+ consent 
Allograft implantation 
Screening at 3 months post op. 
positive 
negative 
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IMPLANTATION 
Pre operative recipient consent and screening were done. 
Allograft preparation 
Decartilaginising the femoral head, the cancellous core is 
morcellised into bits, and triple washed and RINSED to 
remove the fatty marrow. The morcellised bits are placed in 
an antibiotic solution ( cefotaxime 1 gm) prior to grafting. 
 
 
 
 
 
 
 
Graft  bed preparation 
Adequate preparation of the graft bed plays a long term role 
in the incorporation of allografts. The posterolateral mass of 
the dorsolumbar spine (transverse process, facet jts,) are 
shingled after soft tissue denudation.  Placement  of the 
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allograft on a properly prepared host bony bed was found to 
give better fusion rates among allografts.  
Adequacy of allografts was ensured to facilitate a solid bony 
mass formation.  
 
TOTAL NO OF CASES : 20 patients 
Male : female  = 14 : 6 
Mean age: 39.10 yrs (17 – 55 yrs) 
Trauma  
Burst fracture 
Fracture dislocation 
11 patients 
10 
1 
55 % 
Degenerative  
Degen. Spondylolisthesis 
Lytic spondylolisthesis 
 7 patients 
6 
1 
35 % 
Caries spine  
Dorsal 
Lumbar  
2 patients 
1 
1 
10 % 
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trauma 
degenerative
caries 
 
 
Investigations  
After appropriate radiographs pre operative CT scan was a must to assess the 
canal dimensions and the anatomy of the Posterolateral structures. 
Pre operative- 
Bladder and bowel care as necessary given. Alpha beds were provided for 
prevention of pressure sores. 
Intraoperative- 
Anaesthesia – general Anaesthesia 
Average duration of surgery-  1 hr 50 min 
Avg time of graft preparation – 30 min 
Implants used K fixator 
   Pedicle screws  
  Hartshill rectangles 
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   POST OP PROTOCOL 
 
a. drain removal after 48 hrs. 
b. mobilization (sitting up) after drain removal with external 
brace. 
c. Suture removal – 12 th post op day. 
d. Back, bladder, bowel care taught. 
e. External orthosis used for 8 weeks. 
f. Advised review  after 6 weeks 
g. Screening of the patient at 3rd month. 
h. Follow up every 3 m. 
i. CT scan at each follow up 
 
The Lenke’s grading was used at each review session for assessment of fusion. 
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ILLUSTRATION 
 
OF 
 
CASES 
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 CASE I 
 
Perumal  30/M     
  
L5S1 lytic spondylolisthesis with radiculopathy. 
 
ORIF with  Kluger’s Fixator 
 
Complications: nil  
 
Type of graft implantation: Allo- Autograft mixture. 
 
Lenke’s grading @ maximum follow up (24m) – Gr 1 
6m - Gr 2 
9m - Gr 2 
12m - Gr 1 
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CASE I 
 
PRE OPERATIVE POST OPERATIVE 
 
       
 
 
CT scan at 9 m 
 
 
 
CT scan at 16 m 
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CASE II 
 
Rani  45/ F 
 
L4-L5 degenerative spondylolisthesis 
 
Decompression + insitu fusion ( No implant) 
 
Allograft type : Pure allograft 
 
Complications: Nil 
 
Lenke’s grading at maximum follow up ( 17 m) Gr 4 
 
6m - Gr 3 
9m - Gr 4 
12m -  Gr 4 
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Case  I I 
 
 
 
 
 
 
 
 
 
 
 
CT at 16 months with loss of the allograft 
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CASE III 
RAMA RAO 55/ M 
 
 
D12 BURST FRACTURE + PARAPLEGIA 
 
 
POSTERIOR STABILISATION ( PEDICLE SCREWS & RODS) 
 
 
TYPE OF ALLOGRAFT: PURE ALLOGRAFT 
 
 
COMPLICATIONS: NIL 
 
 
LENKE’S GRADING AT MAXIMUM FOLLOWUP (14m)- Gr 4 
3m    - Gr 3 
9m  - Gr 4  
12m -  Gr 4 
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CASE III 
Pre operative 
      
Post Operative 
         
 66
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CASE  IV   
 
VASANTH 18/M 
 
L2 FRACTURE + PARAPLEGIA 
 
POSTERIOR STABILISATION  (PEDICLE SCREWS & RODS). 
 
TYPE OF ALLOGRAFT : PURE ALLOGRAFT 
 
LENKE’S GRADING AT MAX. FOLLOW UP - Gr 2 
 
3m - Gr 3 
6m - Gr 3 
10m - Gr 2 
 
 
 
 
COMPLICATIONS: NIL 
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CASE  IV 
 
 
PRE OPERATIVE   POST OPERATIVE 
 
     
 
 
CT Scan at 10  m 
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CASE V 
 
SABANA BASHIR 51/F 
 
L5 S1   DEGEN. SPONDYLOLISTHESIS +  RADICULOPATHY 
 
ORIF + PEDICLE SCREWS 
 
TYPE OF GRAFT:  
RT SIDE –  PURE ALLOGRAFT 
LT SIDE  -  PURE AUTOGRAFT 
 
COMPLICATIONS: NIL 
 
LENKE’S GRADE AT MAX. FOLLOW UP –  
 
RT SIDE – Gr 3 
 
LT SIDE -  Gr 2  
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CASE  V 
 Pre operative    Post  operative 
   
Better fusion seen with autografts on the left 
 
 
 
CT scan at  7 months 
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   RESULTS 
 
 
 
 
 72
 
Follow up 
 
At every follow up CT scan was taken to assess the radiological level of fusion. 
Maximum follow up: 24 months 
Minimum follow up : 7 months 
Mean follow up   : 11 months 
No. of cases lost to follow up : 3 patients  
(1 pt post discharge + 2 pts after one year of follow up) 
No . of house visits done : 2 
Assessment of fusion was done using the Lenke’s fusion grading 
LENKE’S GRADING OF FUSION 
GRADE 1 Solid, big trabeculated fusions bilaterally(definitely solid) 
GRADE 2 Solid, big fusion mass unilaterally with a small fusion mass 
on the contralateral aspect (possibly solid) 
GRADE 3 Small, thin fusion masses bilaterally with apparent crack 
(probably not solid) 
GRADE 4 Graft resorption bilaterally or fusion mass with an obvious 
bilateral pseudarthrosis (definitely not solid).  
Maximal fusion  achieved was  Gr  1  Minimal fusion was - Gr 4 
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Lenke’s 
grading 
No.of 
patients 
Achieved at Max  
follow up 
Percent  
Gr 1  1 12 m 24 m 5 % 
Gr 2  10 12 m avg 16 m 50 % 
Gr 3  6  10 m 30 % 
Gr 4 2  @ 12m 16 m 10 % 
 
Type of graft No. of  
pts  
Max. Lenke’s 
grading 
Time 
taken  
Min. grade 
achieved 
Pure allograft 16  Gr. 2 12 m Gr 4 
Allo- Auto mixture 3 Gr. 1 12 m Gr 2 
Pt. no 18 
Rt side – allograft 
 
Lt side - autograft 
 
 
 
Gr. 3 
 
Gr. 2 
 
  
@ 7 m 
 
Type of implant No. of  
pts  
Max. Lenke’s 
grading 
Time 
taken  
Min. grade 
achieved 
K fixator 1  Gr. 1  12 m  
Pedicle screws 16  Gr. 2  10 m Gr 4 
(improper fixn) 
No implants 
(in situ fusion) 
1 
 
 
 Gr. 4 
(graft resorption) 
 
 
 
 16 m 
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Fusion at 12 months in different 
implants
0
1
2
3
4
0 5 10 15
K fixator
pedicle screws
no implant
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OVER ALL FUSION 
0 5 10 15 20
Gr I
Gr II
Gr III
Gr IV
 
Gr I
Gr II
Gr III
Gr IV
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ANALYSIS OF RESULTS 
Grade 2 fusion levels were considered as reasonably enough to take the 
load shared by the implant off. This level of fusion was achieved in 10 cases.  
Grade one fusion was seen in one case.  
In order to compare the fusion rates with autograft added for osteo-induction 3 
patients were embedded with auto – allograft mixture . They showed gr 2 fusion 
at 9m . 
Neurological recovery was not a criteria in our evaluation. 
Stability of fixation was an important criteria 
Two cases of graft resorption were seen in those without implants or with 
improper, unstable fixation.One patient (L5S1 listhesis) had no implants, with 
decompression and in situ allografting. Though patient is symptom free, there 
was complete resorption of the allograft on the follow up CT at 16 months. 
In one case( Case 18) of spondylolisthesis allograft were packed on the rt 
side with autograft on the left side. At 7 months follow up there was Grade 2 
fusion at the autograft side while the allograft side showed Gr 3 patchy fusion, 
thereby demonstrating the slower fusion rates with allografts. 
The mean period for achieving gr 2 fusion was 12 months. 
There were no allograft associated complications like: 
• Post op wound infection 
• Graft rejection reactions.(manifesting as sterile discharges) 
• Transmission of diseases  
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             DISCUSSION 
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Allografting is a revolutionary procedure in the treatment of patients. 
To obtain a solid fusion in complex spinal problems, surgeons face both 
mechanical and biological difficulties. 4 factors affect the fusion of grafts 
in spinal fusion surgeries. They  are: 
• Osteogeneic potential 
• Osteoinductivity  
• Osteoconductivity 
• Vascularity of the bed  
 
With allografts only osteoconduction is possible, therefore their use 
being to predominantly augment the quantity of the graft. Hence also 
the importance of preserving the bed vascularity & ensuring proper 
preparation. Also  a long segment of diseased spine or deviation from 
the mechanical advantages, such as a flat back or scoliosis, 
compromises the fusion rate when spinal fusion is attempted. 
  
[Cummine et al. reported 59 patients who had pseudarthrosis status post-
spinal fusion for scoliosis.The fusion rate was only 65%. ] 
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[Lauerman et al. reported 51 patients with 63 pseudarthrose after 
posterior spinal fusion for idiopathic scoliosis. 56% had more than one 
level of pseudarthrosis. 40% of pseudarthrosis were in the lumbar spine.] 
 
[Raney et al. found 53% of pseudarthrosis in 66 patients had 
underlying metabolic conditions such as osteoporosis, malabsorption 
syndrome, phosphate depletion secondary to antacid use, vitamin D 
abnormality or excessive tobacco or alcohol consumption.] 
 
In our series the need to eliminate such factors predisposing to 
pseudarthrosis was felt. Hence exclusion criteria were framed regarding 
extremes of age ( age >55 yrs), general nutritional status, metabolic bone 
disorders, history of previous spine surgery and other co-morbid 
conditions 
It has been accepted that autogenous bone graft is preferable in 
both posterior and anterior fusion; however, often the amount of such 
bone graft is not enough either because it has been harvested from 
previous surgery or multiple levels of surgery are indicated.  
Kozak et al. in 1994,[7] described the technique of anterior 
interbody fusion by using a femoral ring allograft packed with 
autogenous chip grafts to provide a strong construction to support the 
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spine anteriorly. The authors emphasized the preparation of the vertebral 
end plates as an essential technique.  
 
In our series, 2 cases( caries spine) of anterior interbody fusion 
with femoral cortical ring allograft with autograft packing produced grade 
II Lenke’s fusion at 12 m follow up. The slower rate of graft 
incorporation could be attributed to: 
• delay in incorporation of the cortical bone of the femoral ring 
allograft (though the purpose of the autograft pack was solely to 
increase the rate and chance of fusion of the interbody graft) 
• the presence of an infective foci at the site of fusion( caries ) 
• higher biomechanical loads in the dorso lumbar spine. 
 
These 2 cases would only be a representation but cannot be compared 
to  Kozak’s series.[7] 
An, Toth, and Lynch  (1995) in their study have compared the rates 
of fusion of  pure autografts, pure allografts , allo- autograft mixtures in 
spinal surgery fusion. Their results show that rate of fusion is the 
maximum with pure autografts followed by mixture grafts. Pure allografts 
have been shown to have the slowest rates of fusion. They have also been 
associated with the most no. of complications like pseudarthrosis, fusion 
fracture.[3] 
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Similar results were obtained with our study where 3 cases with 
allo-auto graft mixtures provided faster and better fusion results (grade 2 
at a mean time of 9 months). 
Nather ,Thambiah in 1996 have shown nearly 60 % fusion 
rateswith pure allografts, but justify their lower fusion rates with their 
contention that fusion of allografts though delayed, it was  useful in older 
patients with porotic Iliac crests unsuitable for  autograft harvesting.[4] 
In our study the use of allografts in degenerative spinal diseases 
has provided good fusion (50%) . This fusion was Gr 2 at  12 m follow 
up. These patients need further follow up to assess the time required  for 
Gr 1 fusion levels to be achieved. 
In anterior fusion, the allograft, especially cortical bone of the 
femoral ring, required a considerable time before the full incorporation of 
the graft would take place. Kozak’s was a larger series with purely 
anterior ring allografts for fusion. It appeared that at least 18 months is 
required before the majority of the grafts would be fully incorporated to 
the host bone.  
One case in this study had a persistent radiolucent line at the 
interface between the graft and the shingled posterolateral surface. 
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The following is the analysis of the primary reference articles in 
comparison with this study 
 
 
Nather & 
Thambiah 
1996 60% fusion rates with allografts 
In degenerative cases. Failure of fusion noted in 
cases with Hartshill fixation. 
 
Kozak  1995 97% fusion with femur allograft in ALIF 
An, Toth 1995 Allo- auto mix provided 50% faster fusion than 
pure allografts 
This study 2008 50% fusion rates with allo- auto mix. 
Implant stability plays major role in fusion rates 
Longer time (12m for Gr 2) required for fusion than 
autografts. 
Needs prolonged external orthoses for better results. 
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CONCLUSION 
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Bone autografting remains the most effective  grafting 
material as it provides all the 4 essentials of bone regeneration. 
However the shortcomings of large harvesting and its associated 
morbidity provides us the scope for other alternatives. Among 
these alternatives allografts are the most inexpensive, most readily 
available option. 
The attainment of solid bone fusion is multifactorial. There is a 
race between bone resorption and new formation in seeking to create a 
new fusion mass which can withstand mechanical loads. The following 
are the various conclusions regarding the multiple factors that governed 
allograft fusion in this study.  
Deep Frozen Irradiated allografts have the maximum 
retention of  their strength and structure. 
There was NO infection during the use of these Irradiated 
allografts.  
 In anterior fusion the allograft, especially cortical bone of the 
femoral ring, required a considerable time before the full incorporation of 
the graft would take place. It appeared that at least 18 months is required 
before the majority of the grafts would be fully incorporated to the host 
bone.  
 85
Another major conclusion  was regarding External Bracing post 
operatively. In properly selected patients with extended external post 
operative immobilization the rates of fusion of allografts are better . 
The stability of the implant as a factor for fusion needs to be 
stressed. Faster rates of fusion were seen in the more stable spine. The 
best result (Gr I) was achieved with a Klueger fixator. 
The  quality and the quantity of the allografts. With allografts 
there is everlasting quantity and mixing of minimal quantity of autografts 
provides the osteoinductive impetus to achieve faster fusion. Meticulous 
bed preparation yielded good results  
Allografts are definitely a boon in the older age group with 
osteoporotic iliac crests. 
Thus allografts are a definite solution for the problem of large bone 
harvests. Based on the review of our literature  we conclude that bone 
allografts are a reliable and inexpensive alternative to autografts in spine 
fusion surgery.  
 
 
 
                         
 86
     
 
 
BIBLIOGRAPHY 
 
 
 
 
 
 
 
 87
1. Norbert Dion and Franklin H. Sim  The Use of Allografts 
in Orthopaedic Surgery  J. Bone Joint Surg. Am., Apr 
2002; 84: 644 - 654. 
2. American association of tissue banks (1987)standard for 
tissue banking. Arlington,Virginia : American association for 
Tissue Bank 
3. Prospective comparison of autograft vs. allograft for adult 
posterolateral lumbar spine fusion: differences among freeze-dried, 
frozen, and mixed grafts AN H. S. ; LYNCH K. ; TOTH J. ; 
Journal of spinal disorders   1995, vol. 8, no2, pp. 131-135 (15 ref.) 
4. NatherA, ThambiahJ,Lee. Spinal fusion with allografts. 
proceedings at 7th international conference on biomeicals. J 
ASEAN Orthop pp 249-251. 
5. Fujimaki A, Crock HV, Bedbrook GM. The results of 150 
anterior lumbar interbody fusion operations performed by two 
surgeons in Australia. Clin Orthop 1982, 165:164-7. 
6.  Hurley LA, Stinchfield FE, Bassett AL, Lyon WH. The role of 
soft tissues in osteogenesis. J Bone Joint Surg [Am] 1959, 
41A:1243-66. 
 88
7. Kostuik JP, Carl A, Ferron S. Anterior interbody fusion and 
instrumentation for lumbar degenerative disc disease [unpublished 
data]. 1987. 
8. Kozak JA, Heilman AE, O’Brien JP. Anterior lumbar fusion 
options Clin Orthop 1994, 300:45-51. 
9. Anderson MJ (1992) Compressive mechanical properties of 
human cancellous bone after gamma radiation. J Bone Joint 
Surg 74:747 
10. Berry BH Jr, Lord CF,Gebhardt MC,Mankin HJ(1990) 
Fractures of allografts. Frequency, treatment and end-result. 
J.Bone Joint Surg 72-A; 825-833. 
11. Buck BE, Malinin T1 Brown MD(1989)Bone 
transplantation in Human Immune Deficiency Virus. An 
estimate of risk of acquired Immune deficiency 
syndrome(AIDS). Clin Orthop 240: 129-136 
12. Connoly J. Injectable bone marrow preparations to 
stimulate  osteogenic repair. Clin Orthop.1995;(313):8-18. 
13. Delloye C, Simon P, Nygjen – Behets C, Bense X, 
Bresler F, Schmitt. D, Perforations of cortical allografts 
improve their information. Clin.Ortho.2002 Mar (396)240–7. 
 89
14. Elves MW. Immunological studies of osteoarticular grafts. 
Proc R soc Med 1971; 64 :644. 
15. Friedlaender GE: Current concepts review: bone banking, J 
Bone Joint Surg(Am) 
16. Hanson PD, Warson C – Effect of intramedullary PMMA and 
autogenous bone on healing of frozen segmental allografts 
J.Orthop Res 1998 May 16 (3) 285 – 92. 
17. Hornick FJ; Gebhardt MC, Tomford WV, Factors affecting 
nonunion of the allograft – host junction Clinc Orthop. 2001 
Jan (382) 87 – 98. 
18. Laurencin CT, Khan Y. Bone graft substitutes materials. 
http://www.emedicine.com/orthoped/topic611.htm.  
19. Malinen T, Martinez OV, BrownMD. Banking of massive 
allografts - 12 year experi Clini Orthop 1985; 197 :44 
20. Musculo DL, Ayerza MA, Afonte – Tinao LA Survivership 
and Radiographic analysis of knee osteoarticular allografts 
21. Stevenson S Shaffer  JW, Goldberg VM. Factors affecting 
bone graft incorporation. Clini Orthop 1996 : 324-66 
22. Stevenson s, emery AE, Goldberg VM. Factors affecting 
bone graft incorporation. Clin Orthop 1996:324:66 
 
 90
23. Urist MR, Bone transplantation and Implants In:Urist MR,ed. 
Fundamental and clinical physiology of Bone. 
Philadelphia:J.B.Lippincott, 1980 
24. Younger EM,Champman MW. Morbidity at bone graft donor 
sites. J Orthop Trauma 1989; 3(3):192-5. 
25. Zapstein HD, Burdygin YN. Replacement of the distal femur 
and proximal tibia with frozen allografts Clini Orthop 1994 ; 
303:95 
 
 
 
 
 
 
 91
 
 
 
PROFORMA 
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OUTCOME ANALYSIS OF THE USE ALLOGRAFTS IN SPINE 
FUSION SURGERIES 
 
 
CASE PROFORMA 
 
 
CASE NO : 
 
UNIT       : 
 
NAME           :      D.O.A          : 
 
AGE               :      D.O.INJURY : 
 
SEX                :      D.O.S           : 
 
I.P.NO.           :      D.O.D          : 
 
ADDRESS     :      MODE OF INJURY : 
 
 
 
 
 
 
 
DIAGNOSIS : 
 
 
PROCEDURE : 
 
 
 
 
 
COMORBID FACTORS: 
 
CONSENT FOR PARTICIPATION: 
 
PREOPERATIVE SCREENING: 
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 NEUROLOGY ON ADMISSION : 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RADIOLOGICAL FINDINGS : 
 
X ray : 
 
CT  : 
 
 
 
 
    SURGERY DETAILS 
     
 
PROCEDURE  : 
 
ANAESTHESIA :                                                   POSITION :  
 
APPROACH :                                          
 
DURATION  :                                                         BLOOD LOSS :   
 
INSTRUMENTATION :     
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    ALLOGRAFT DETAILS 
 
 
TYPE OF ALLOGRAFT: 
 
DONOR NO & SCREENING: 
 
MODE OF STERILISATION: 
 
STORAGE  : 
 
PREPARATION: 
 
GRAFT IMPLANTATION: 
 
 
 
 
 
 
  
POST OPERATIVE PERIOD 
 
DRAIN REMOVAL: 
 
INFECTION : 
 
STERILE DISCHARGE: 
 
POST OP NEUROLOGY: 
 
 
 
 
 
 
 
 
POST OP RADIOLOGY :        
 
PHYSIOTHERAPY AND REHABILITATION : 
 
DISCHARGED ON: 
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FOLLOW UP  with LENKE’ S grading  
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ANNEXURES 
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ANNEXURE II 
 
BONE BANK DONOR CONSENT FORM 
 
 
ANNEXURE III 
 
PATIENT CONSENT FORM 
 
 
ANNEXURE IV 
 
RECIPIENT RECORD 
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MASTER CHART 
No Name  
Age 
Sex I.P.no Diagnosis Neurology D.o.S 
Procedure 
 
Allograft 
Details 
Donor   
recipient 
Compln
Infecn 
Follow up  –  
Lenke’s grading 
3m 6m  9m  12   
(max) 
1. Chandran  55/M 801168 D9-10 
caries spine 
paraplegia 09.06.06 Ant.decomp+ tibial cort. 
Ring allograft+ autograft 
pack 
LSAG 
35 
LR 
18 
nil    2   L 
2 Malliga  45/F 794737 L3 caries 
spine 
L/L    4/5 16.6.06 Ant.decomp+  
fem ring allograft 
+ autograft pack 
LSAG 
37 
LR 
19 
nil    2      L 
3 Perumal  30/M 802078 L5S1 
listhesis 
radiculopathy 20.8.06 ORIF + K fixator LD 22 LR21 nil    1   (24 
m) 
4 Rani 45/F 001735 L4-5 
listhesis 
radiculopathy 12.4.07 Decompression +  in situ 
fusion 
LD23, 
24 
LR 
23 
nil    4   
(17m) 
5 Angammal 50/F 031785 L5S1 
listhesis 
radiculopathy 23.5.07 ORIF + Pedicle screws LD25, 
26 
LR 
24 
nil    2    
(16m) 
6 Punniakodi 50/M 27799 D10 # 
disloc 
L/L  2/5 24.5.07 Post.stabilisation + 
pedicle screws 
LD27, 
28 
LR25 nil    2    
(16m) 
7 Murugan 32/M 032812 D12#  
 
L/L   2/5 30.5.07 Post.stabilisation+ 
pedicle screws 
LD29, 
30 
LR26 nil    2    
(12m) 
8 Senthilkumar 30/M 33824 L1 burst# 
 
paraplegia 30.5.07 Post.stabilisation + 
pedicle screws 
LD31-
32 
LR27 nil    2    
(17m) 
9 Kumar 40/M 34814 L5S1 
listhesis 
radiculopathy 12.6.07 ORIF + pedicle screws LD 33  LR 
28 
nil    2    
(16m) 
10. Diwan 37/M 34902 # D10 
dislocn 
L/L 1/5  ORIF + post.Stabil ped 
screws 
LD 21  LR 
20 
nil    2 (16 
m) 
11 Sakthivel 31/M 34962 L1,L2 # 
 
 
Paraplegia 28.6.07 Post.stabilisation + 
pedicle screws 
LD 34 LR 
29 
nil   2      
(14m) 
12 Ramarao 55/M 11802 D12 burst# paraplegia 08.1.08 Post.stabilisation + LD35 LR30 nil   4      
MASTER CHART 
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 pedicle screws (10m) 
 
13 Pakkiri 50/M 12069 D4 burst# 
 
paraplegia 15.1.08 Post.stabilisation + 
pedicle screws 
LD36 LR31 nil           
LOST 
14 Gnanasekar 25/M 12576 L1 burst# 
 
No deficit 15.1.08 Post.stabilisation + 
pedicle screws 
LD 37 LR32 nil   3    (10 
m) 
15 Vasanth 18/M 12118 L2 # paraplegia 16.1.08 Post.stabilisation + 
pedicle screws 
LD 38 LR33 nil   2    (10 
m) 
16 Raja 45/M 12312 D11 burst # 
 
paraplegia 20.1.08 Post.stabilisation + 
pedicle screws 
LD 39 LR34 nil   3    (10 
m) 
17 Purushotaman 17/M 14224 L1-2 # L/L   3/5 05.03.08 Post.stabilisation + 
pedicle screws 
LD40, 
41 
LR 
36 
nil  3     (7 m) 
18 Vasantha 40/F 14468 L5S1 
listhesis 
 
radiculopathy 12.3.08 ORIF + pedicle screws LD46, 
47 
LR 
37 
nil  3     (7 m) 
19 Sabana bashir 51/F 15110 L4L5 
listhesis 
 
radiculopathy 20.3.08 ORIF + pedicle screws LD57, 
58 
LR39 nil  3     (7 m ) 
20 Selvam 34/M 15221 L1 burst # paraplegia 22.3.08 Post.stabilisation + 
pedicle screws 
LD62, 
63 
LR 
41 
nil  3     (7 m ) 
 
 
 
